ARTICLE | Company News
Constellation, LLS deal
October 1, 2012 7:00 AM UTC
The society will provide up to $7.5 million in funding to support development of Constellation's small molecule BET inhibitors to treat hematologic malignancies through Phase I testing. The partners d...